Solid-tumor research hopefuls visit for interviews, seminars

Brief
January 16, 2003

Candidates for positions in solid-tumor research and oncology had interviews and gave seminars in the Clinical Research Division in late 2002. Dr. Fred Appelbaum, division director, said he hopes at least one offer will be made in the spring.

Lab-based

One search is for one or more lab-based investigators to promote development of treatments or diagnostic tools for solid tumors.

Candidates may have doctoral or medical degrees, can be junior- or senior-level researchers and can work on any of a number of different cancer types.

"We haven't limited the search to specific diseases, but we'd like to recruit researchers whose interests will complement existing solid-tumor research strengths in our division and the other divisions," Appelbaum said. "So the diseases we're most interested in are cancers of the prostate, ovary, breast, and colon and gastrointestinal tract."

The recent candidates include Dr. Norman Greenberg, Baylor College of Medicine, who has developed mouse models of prostate cancer; Dr. Matthew Albert, Rockefeller University, who has developed immune-based cancer therapies; and Dr. William Grady, Vanderbilt Medical Center, who studies the genetics of colon cancer development.

Senior oncologist

The second open position is for a senior solid-tumor oncologist who would serve as associate director of clinical research, associate head of the University of Washington Division of Medical Oncology and director of the Research Trials Office, which oversees a number of human-subjects research support services available to center and UW investigators.

Appelbaum said this faculty member will be based at the Seattle Cancer Care Alliance and recruit junior faculty with solid-tumor oncology expertise.

Candidates recently interviewed for that position include Dr. Michael Bookman of the Fox Chase Cancer Center, a gynecologic oncologist, and Dr. Dan Petrylak of Columbia-Presbyterian Medical Center, a urologic oncologist.

Dr. Arlene Forastiere, of The Johns Hopkins University School of Medicine and an expert in research and treatment of upper-respiratory and gastrointestinal cancers, will visit in February.

Center News Table of Contents